Simplex Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$217K Buy
7,227
+7,153
+9,666% +$237K ﹤0.01% 4214
2025
Q4
$2.42K Sell
74
-180
-71% -$5.81K ﹤0.01% 7772
2025
Q3
$8K Buy
+254
New +$8.13K ﹤0.01% 8020
2025
Q2
Sell
-1,724
Closed -$46.2K 9036
2025
Q1
$43K Buy
+1,724
New +$43.6K ﹤0.01% 5915
2024
Q3
Sell
-9,178
Closed -$250K 8884
2024
Q2
$227K Buy
9,178
+8,793
+2,284% +$250K ﹤0.01% 4539
2024
Q1
$12K Buy
+385
New +$14.3K ﹤0.01% 7470
2023
Q3
Sell
-1,355
Closed -$52.7K 9059
2023
Q2
$55K Sell
1,355
-6,249
-82% -$255K ﹤0.01% 5745
2023
Q1
$293K Buy
+7,604
New +$313K ﹤0.01% 3859
2022
Q2
Sell
-1,994
Closed -$118K 10344
2022
Q1
$123K Buy
+1,994
New +$122K ﹤0.01% 5849
2020
Q4
Sell
-5,432
Closed -$664K 8583
2020
Q3
$770K Sell
5,432
-13,451
-71% -$2.24M ﹤0.01% 2535
2020
Q2
$3.73M Buy
18,883
+4,872
+35% +$1.01M 0.01% 1042
2020
Q1
$2.75M Buy
14,011
+2,391
+21% +$514K ﹤0.01% 1050
2019
Q4
$2.4M Buy
11,620
+11,584
+32,178% +$2.14M 0.01% 1323
2019
Q3
$5K Sell
36
-13,173
-100% -$2.16M ﹤0.01% 6601
2019
Q2
$1.7M Buy
+13,209
New +$1.57M ﹤0.01% 1433
2019
Q1
Sell
-18
Closed -$1.81K 7353
2018
Q4
$1K Buy
+18
New +$1.82K ﹤0.01% 6738
2018
Q1
Sell
-98
Closed -$10.6K 6390
2017
Q4
$9K Buy
+98
New +$9.27K ﹤0.01% 3987
2017
Q3
Sell
-200
Closed -$15K 6146
2017
Q2
$15K Buy
+200
New +$16.8K ﹤0.01% 3571

Other funds holding LKFT

Simplex Trading's LKFT Position: Q1 2026 in Review

Simplex Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9,666% in Q1 2026, buying an estimated $237K and bringing the position to 7,227 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #4214.

Simplex Trading first reported a position in LKFT in Q2 2017 and has held it in 18 quarters since. The position peaked at $3.73M in Q2 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Simplex Trading held 7,227 shares of Lakefront Biotherapeutics American Depositary Shares worth $217K as of Q1 2026.
  • Simplex Trading bought 7,153 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $237K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4214 holding.
  • Simplex Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and has held it in 18 quarters since.
  • Simplex Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.73M in Q2 2020.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.